Patents Assigned to MURRAY AND POOLE ENTERPRISES LIMITED
  • Patent number: 10130585
    Abstract: Methods of treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein are provided.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: November 20, 2018
    Assignee: Murray and Poole Enterprises Limited
    Inventor: Susanne Riel
  • Publication number: 20180318221
    Abstract: Pharmaceutical compositions of colchicine salicylate, including once-a-day orally administered formulations are provided. Method of treating and/or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: April 15, 2016
    Publication date: November 8, 2018
    Applicant: Murray and Poole Enterprises Limited
    Inventor: Susanne Riel
  • Patent number: 10105319
    Abstract: Pharmaceutical compositions of colchicine for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined or desired release profile. Methods of treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein are also provided.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: October 23, 2018
    Assignee: Murray and Poole Enterprises Limited
    Inventor: Susanne Riel
  • Patent number: 9744144
    Abstract: Methods of treating and/or preventing a cardiovascular event in a patient, the method comprising orally administering a colchicine to a patient who is receiving concurrent treatment with at least one antiplatelet agent, thereby treating and/or preventing the cardiovascular event in the patient are provided.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: August 29, 2017
    Assignee: Murray and Poole Enterprises Limited
    Inventor: Mark Nidorf
  • Publication number: 20160081936
    Abstract: Pharmaceutical compositions of colchicine for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined or desired release profile. Method of treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: April 16, 2014
    Publication date: March 24, 2016
    Applicant: MURRAY AND POOLE ENTERPRISES LIMITED
    Inventor: Susanne Riel